maxon looks back on a challenging fiscal year 2023, as the annual financial report shows. Sales in 2023 amounted to CHF 664.4 million (compared to CHF 707.7 million in 2022). Various reasons led to this result, but the main reason was currency losses, which cost maxon more than CHF 35 million. However, maxon believes in the future and hence increased spending on research in 2023 to CHF 53.6 million (from CHF 51.5 million in 2022). Despite the difficult year, maxon’s management is satisfied with the present results. Eugen Elmiger, CEO of maxon Group (left in the picture), says: “Despite the challenging economic environment and the decline in sales, maxon remains determined to invest in the future. Our increased investment in research and development underlines our commitment to driving innovation and strengthening our market position.” Dr. Karl-Walter Braun, main shareholder and Chairman of the Board of Directors of maxon Group (right in the picture), says of the result: “The average growth of the last 5 years is still around plus 4 percent per year. A great achievement in these crisis years!” Want to know more? You can find our latest media release here: https://lnkd.in/duTy65Jv
Despite the challenges great to be part of the Maxon family.
Gratuliere zum tollen Geschäftserfolg, lieber Eugen! Weiter so!
Marketing & Sales. Office Manager
2wProud to be part of the maxon Group.